Showing results (491-500 of 6,537) with videos related to

Sort By:
Pageof 654
Brain Research|March 9, 1981
Age-dependent changes in the beta-endorphin content of discrete rat brain nucleiN Barden, A Dupont, F Labrie, et al.
Steroids|June 1, 1995
The enzyme and inhibitors of 4-ene-3-oxosteroid 5 alpha-oxidoreductaseX Li, C Chen, S M Singh, et al.
Science (New York, N.Y.)|May 28, 1982
Corticotropin-releasing factor stimulates accumulation of adenosine 3', 5'-monophosphate in rat pituitary corticotrophsF Labrie, R Veilleux, G Lefevre, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1982
Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid actionV Giguère, F Labrie, J Côté, et al.
DNA and Cell Biology|December 1, 1991
Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and gonadal specificityY Lachance, V Luu-The, H Verreault, et al.
Breast Cancer Research and Treatment|July 1, 1989
Beta-adrenergic receptors in DMBA-induced rat mammary tumors: correlation with progesterone receptor and tumor growthB Marchetti, P G Spinola, M Plante, et al.
Urology|January 14, 1998
Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activityS Luo, C Martel, C Chen, et al.
Endocrinology|May 1, 1979
Inhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female ratsL Cusan, C Auclair, A Belanger, et al.
Endocrinology|March 6, 1999
Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistryM El-Alfy, V Luu-The, X F Huang, et al.
Prostate Cancer and Prostatic Diseases|June 25, 2008
Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonistsI M Spitz, B Chertin, A Fridmans, et al.
Pageof 654